Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Deerfield Capital Management
AddedFeb 13, 2024
UpdatedJun 28, 2026
Deerfield Capital Management

Deerfield Capital Management

Operating

DCM: A global fixed-income investment adviser and business services provider since 1993.

Location
Chicago, IL, US
Founded
1994
Firm
Compare
Portfolio
Employees

Deerfield Capital Management (''DCM'') is a global fixed-income investment

adviser that has managed institutional, alternative accounts since 1993.

Deerfield Capital Management - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments34
Current Portfolio Count23
Total Portfolio Exits5

Top Investment Stages

Series B6 (28.6%)
Series D5 (23.8%)
Series Unknown4 (19.0%)
Series A3 (14.3%)
Series C3 (14.3%)

Stage Mix

Series B 29%Series D 24%Series Unknown 19%Series A 14%Series C 14%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Adaptive Phage Therapeutics logo

Adaptive Phage Therapeutics

Epic Sciences logo

Epic Sciences

ConcertoCare logo

ConcertoCare

Quartet Health logo

Quartet Health

Revolution Medicines logo

Revolution Medicines

Acutus Medical logo

Acutus Medical

Stelexis Therapeutics logo

Stelexis Therapeutics

Ribon Therapeutics logo

Ribon Therapeutics

Mirum Pharmaceuticals logo

Mirum Pharmaceuticals

NeoChord logo

NeoChord

Allogene Therapeutics logo

Allogene Therapeutics

Alector logo

Alector

Appello Pharmaceuticals logo

Appello Pharmaceuticals

Strata Oncology logo

Strata Oncology

Fog Pharmaceuticals logo

Fog Pharmaceuticals

Braeburn logo

Braeburn

Johns Hopkins University logo

Johns Hopkins University

Conventus Orthopaedics logo

Conventus Orthopaedics

Rhythm Pharmaceuticals logo

Rhythm Pharmaceuticals

Invitae logo

Invitae

Nuo Therapeutics logo

Nuo Therapeutics

Foundation Medicine logo

Foundation Medicine

Hana Biosciences logo

Hana Biosciences

Arena Pharmaceuticals logo

Arena Pharmaceuticals

Cardiomems logo

Cardiomems

Deerfield Capital Management - Similar Investment Firms

Deerfield Management logo

Deerfield Management

deerfield.com

Drake Management logo

Drake Management

Deep Field Asset Management logo

Deep Field Asset Management

Digital Capital Management logo

Digital Capital Management

Davidson Kempner Capital Management logo

Davidson Kempner Capital Management

Westfield Capital Management logo

Westfield Capital Management

DFE Capital Management logo

DFE Capital Management

Focus Capital Partners logo

Focus Capital Partners

Capital World Investors logo

Capital World Investors

Deuterium Capital Management logo

Deuterium Capital Management

deuterium.us

White Deer Management logo

White Deer Management

Adelphi Capital logo

Adelphi Capital

Duquesne Capital Management logo

Duquesne Capital Management

DCM logo

DCM

dcm.com

Desai Capital Management logo

Desai Capital Management

Deerfield Capital Management - Classification

Also Known As
  • Deerfield Capital Management Europe Ltd
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end
Show 2 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
SIC
  • 6000Depository Institutions